Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1999-4-13
pubmed:abstractText
Autocrine interaction of Fas and Fas ligand leads to apoptosis of activated T cells, a process that is critical for the maintenance of peripheral T cell tolerance. Paracrine interactions of Fas ligand with T cells also may play an important role in the maintenance of tolerance, as Fas ligand can create immune-privileged sites and prevent graft rejection by inducing apoptosis in T cells. We surmised that APCs that express Fas ligand might directly induce apoptosis of T cells during presentation of Ag to the T cells, thus inducing Ag-specific, systemic T cell tolerance. Here, we show that profound, specific T cell unresponsiveness to alloantigen was induced by treatment of H-2k mice with H-2b APCs that expressed Fas ligand and that profound T cell unresponsiveness specific for the H-Y Ag was induced by treatment of H-2Db/H-Y TCR transgenic female mice with H-2Db/H-Y APCs that expressed Fas ligand. The induction of this systemic T cell tolerance required the expression of Fas ligand on the APCs as well as the expression of Fas on the T cells. The tolerance was restricted to the Ag presented by the APCs. The rapid and profound clonal deletion of the Ag-specific, peripheral T cells mediated by the Fas ligand-expressing APCs contributed to the induction of tolerance. These findings demonstrate that Ag-specific T cell tolerance can be induced by APCs that express Fas ligand and suggest a novel function for APCs in the induction of T cell apoptosis. Furthermore, they indicate a novel immunointervention strategy for treatment of graft rejection and autoantigen-specific autoimmune diseases.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
162
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1423-30
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:9973398-Animals, pubmed-meshheading:9973398-Antigen-Presenting Cells, pubmed-meshheading:9973398-Antigens, CD95, pubmed-meshheading:9973398-Apoptosis, pubmed-meshheading:9973398-Fas Ligand Protein, pubmed-meshheading:9973398-Female, pubmed-meshheading:9973398-H-2 Antigens, pubmed-meshheading:9973398-H-Y Antigen, pubmed-meshheading:9973398-Immune Tolerance, pubmed-meshheading:9973398-Isoantigens, pubmed-meshheading:9973398-Lymphoid Tissue, pubmed-meshheading:9973398-Macrophages, pubmed-meshheading:9973398-Male, pubmed-meshheading:9973398-Membrane Glycoproteins, pubmed-meshheading:9973398-Mice, pubmed-meshheading:9973398-Mice, Inbred C57BL, pubmed-meshheading:9973398-Mice, Inbred MRL lpr, pubmed-meshheading:9973398-Mice, Transgenic, pubmed-meshheading:9973398-Receptors, Antigen, T-Cell, pubmed-meshheading:9973398-T-Lymphocytes
pubmed:year
1999
pubmed:articleTitle
Induction of specific T cell tolerance by Fas ligand-expressing antigen-presenting cells.
pubmed:affiliation
Division of Clinical Immunology and Rheumatology, University of Alabama, Birmingham, AL 35294, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't